...
首页> 外文期刊>Clinical cardiology. >Mortality implications of angina and blood pressure in hypertensive patients with coronary artery disease: New data from extended follow-up of the International Verapamil/Trandolapril Study (INVEST)
【24h】

Mortality implications of angina and blood pressure in hypertensive patients with coronary artery disease: New data from extended follow-up of the International Verapamil/Trandolapril Study (INVEST)

机译:高血压冠心病患者心绞痛和血压对死亡率的影响:国际维拉帕米/ Trandolapril研究(INVEST)延长随访的新数据

获取原文
获取原文并翻译 | 示例
           

摘要

Background Angina and hypertension are common in patients with coronary artery disease (CAD); however, the effect on mortality is unclear. We conducted this prespecified analysis of the International Verapamil/Trandolapril Study (INVEST) to assess relationships between angina, blood pressure (BP), and mortality among elderly, hypertensive CAD patients. Hypothesis Angina and elevated BP will be associated with higher mortality. Methods Extended follow-up was performed using the National Death Index for INVEST patients in the United States (n = 16 951). Based on angina history at enrollment and during follow-up visits, patients were divided into groups: persistent angina (n = 7184), new-onset angina (n = 899), resolved angina (n = 4070), and never angina (n = 4798). Blood pressure was evaluated at baseline, during drug titration, and during follow-up on-treatment. On-treatment systolic BP was classified as tightly controlled (<130 mm Hg), controlled (130-139 mm Hg), or uncontrolled (≥140 mm Hg). A Cox proportional hazards model was created adjusting for age, heart failure, diabetes, renal impairment, myocardial infarction, stroke, and smoking. The angina groups and BP control groups were compared using the never-angina group as the reference. Results Only in the persistent-angina group was a significant association with mortality observed, with an apparent protective effect (hazard ratio: 0.82, 95% confidence interval: 0.75-0.89, P < 0.0001). Uncontrolled BP was associated with increased mortality risk (hazard ratio: 1.29, 95% confidence interval: 1.20-1.40, P < 0.0001), as were several other known cardiovascular risk factors. Conclusions In hypertensive CAD patients, persistent angina was associated with lower mortality. The observed effect was small compared with other cardiovascular risk factors, such as BP, which were associated with increased mortality.
机译:背景冠心病(CAD)患者常见心绞痛和高血压。但是,对死亡率的影响尚不清楚。我们对国际维拉帕米/ Trandolapril研究(INVEST)进行了这项预先指定的分析,以评估老年高血压CAD患者的心绞痛,血压(BP)与死亡率之间的关系。假说心绞痛和血压升高会导致更高的死亡率。方法采用美国国家死亡指数(INVEST)的国家死亡指数(n = 16 951)进行长期随访。根据入院时和随访期间的心绞痛病史,将患者分为以下几类:持续性心绞痛(n = 7184),新发性心绞痛(n = 899),消退性心绞痛(n = 4070)和永不心绞痛(n = 4798)。在基线,药物滴定和后续治疗期间评估血压。治疗时的收缩压分为严格控制(<130 mm Hg),控制(130-139 mm Hg)或不受控制(≥140mm Hg)。创建了Cox比例风险模型,针对年龄,心力衰竭,糖尿病,肾功能不全,心肌梗塞,中风和吸烟进行了调整。以永不心绞痛组为参考,比较心绞痛组和血压对照组。结果仅在持续型心绞痛组中,观察到的死亡率与死亡率显着相关,并具有明显的保护作用(危险比:0.82,95%置信区间:0.75-0.89,P <0.0001)。不受控制的BP与死亡风险增加相关(危险比:1.29,95%置信区间:1.20-1.40,P <0.0001),以及其他一些已知的心血管危险因素。结论在高血压CAD患者中,持续性心绞痛与较低的死亡率相关。与其他与心血管疾病相关的危险因素(如BP)相比,观察到的影响很小,而这些因素与死亡率增加相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号